Bio Medica Laboratories Submits SDD Compliance Certificate for Q2 FY27
Bio Medica Laboratories Ltd 路 Others (Uncategorized) 路 21 Oct 2026, 4:28 pm
Bio Medica Laboratories Submits SDD Compliance Certificate for Q2 FY27 Bio Medica Laboratories Limited submitted its Structured Digital Database (SDD) compliance certificate for the quarter ended 30th Sep'26, pursuant to Regulations 3(5) and 3(6) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Compliance Officer Khushi Gupta confirmed that an internal, non-tamperable SDD with audit trail capabilities for eight years is fully operational. The company successfully captured all five required Unpublished Price Sensitive Information (UPSI) events during the quarter, including specific details regarding access control, nature of UPSI, and timestamping.
Original exchange filing (PDF)
More announcements from Bio Medica Laboratories Ltd
- Monitoring Agency Report for the half year ended 30th September, 2026, issued by CARE Ratings Limited ( Monitoring Agency ), in respect of the utilization of proceeds raised through Initial Public Offer by the Company 路 14 Nov 2026
- Bio Medica Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the half year ended September 30, 2026 in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) 2015. 路 13 Nov 2026
- Bio Medica Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- BMLL : 13-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 05, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 13, 2026, To consider and approve the financial results for the period ended September 30, 2026 路 13 Nov 2026
- Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 05 Nov 2026
